Dysthyroid optic neuropathy: emerging treatment strategies

PURPOSE: Dysthyroid optic neuropathy (DON) is a rare sight-threatening complication of Graves’ disease. First-line treatment for DON consists of high-dose intravenous methylprednisolone (ivMP), followed by immediate orbital decompression (OD) if the response is poor or absent as recommended by the 2...

Descripción completa

Detalles Bibliográficos
Autores principales: Pelewicz-Sowa, M., Miśkiewicz, P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10261203/
https://www.ncbi.nlm.nih.gov/pubmed/36802028
http://dx.doi.org/10.1007/s40618-023-02036-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10261203/
https://www.ncbi.nlm.nih.gov/pubmed/36802028
http://dx.doi.org/10.1007/s40618-023-02036-0

Ejemplares similares